Top Markets
Coin of the day
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.

QLGN
Classement en actions #35381
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing... Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressing with the STARS blood cleansing system, an innovative DNA/RNA-based device engineered to purify a patient's bloodstream by eliminating tumor-derived substances and viruses. Founded in 1996, Qualigen Therapeutics, Inc. is headquartered in Carlsbad, California.
Prix de l'action
$2.37
Dernière synchronisation: 2025-12-15
Capitalisation boursière
$3.99M
Changement (1 jour)
-5.58%
Changement (1 an)
24.74%
Pays
US
Échange Qualigen Therapeutics, Inc. (QLGN)

Catégorie

Le prix QLGN avec la capitalisation boursière de B
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.
QLGN
$2.37
Capitalisation boursière de Qualigen Therapeutics, Inc.(QLGN)
Capitalisation boursière: $3.99M
En August 2026, Qualigen Therapeutics, Inc. a une capitalisation boursière de $3.99M. Cela fait de Qualigen Therapeutics, Inc. la 35381st entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Qualigen Therapeutics, Inc. du 2015 au 2026
QLGN par rapport au top 5 des plus populaires stocks
Prix pour QLGN L’actif B La capitalisation boursière de B Résultats
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.
$3,237,558 $3.99M
$5.452T +136,605,729.74%
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.
$2,666,371 $3.99M
$4.490T +112,505,001.14%
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.
$2,471,820 $3.99M
$4.162T +104,296,095.78%
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.
$2,183,173 $3.99M
$3.676T +92,116,920.05%
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.
$1,682,385 $3.99M
$2.833T +70,986,607.21%